NCT04552535 2022-01-11A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the LungBoehringer IngelheimCompleted200 enrolled 18 charts